Literature DB >> 32860538

Association between urinary salt excretion and albuminuria in Japanese patients with chronic kidney disease: the Fukuoka kidney disease registry study.

Akiko Fukui1, Masaru Nakayama1, Shigeru Tanaka2, Yuta Matsukuma1, Ryota Yoshitomi1, Toshiaki Nakano2, Kazuhiko Tsuruya3, Takanari Kitazono2.   

Abstract

BACKGROUND: Several large population-based studies have demonstrated that urinary salt excretion (USALT) is associated with albuminuria. However, this relationship has not been assessed in a large cohort study of patients with chronic kidney disease (CKD). Thus, the present study aimed to elucidate whether USALT was independently associated with albuminuria in a large cohort of patients with CKD.
METHODS: This cross-sectional study was conducted in 4075 patients with CKD not on dialysis. USALT (g/day) was estimated from spot urine. Patients were divided into quartiles (Q1-Q4) according to estimated USALT. Multivariable regression models were used to determine whether USALT was independently related to urinary albumin-to-creatinine ratio (UACR) or the presence of macroalbuminuria.
RESULTS: In multivariable linear regression analyses, 1-g/day increment in USALT was significantly associated with log UACR [coefficient 0.098, 95% confidence interval (CI) 0.075-0.121]. In addition, compared with the first USALT quartile, the third and fourth quartiles exhibited significant associations with log UACR (Q3: coefficient 0.305, 95% CI 0.154-0.456; Q4: coefficient 0.601, 95% CI 0.447-0.756). Furthermore, multivariable logistic regression analyses showed that USALT (1-g/day increment) was significantly associated with the presence of macroalbuminuria [odds ratio (OR) 1.11, 95% CI 1.07-1.14]; the third and fourth USALT quartiles exhibited significantly greater risks of macroalbuminuria, compared with the first quartile (Q3: OR 1.33, 95% CI 1.09-1.62; Q4: OR 1.89, 95% CI 1.54-2.32).
CONCLUSIONS: This significant association of USALT with UACR and macroalbuminuria suggests that higher USALT may cause increased albuminuria, thereby contributing to kidney disease progression.

Entities:  

Keywords:  Albuminuria; Chronic kidney disease; Fukuoka kidney disease registry study; Macroalbuminuria; Urinary salt excretion

Year:  2020        PMID: 32860538     DOI: 10.1007/s10157-020-01950-4

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  36 in total

Review 1.  Role of dietary salt and potassium intake in cardiovascular health and disease: a review of the evidence.

Authors:  Kristal J Aaron; Paul W Sanders
Journal:  Mayo Clin Proc       Date:  2013-09       Impact factor: 7.616

2.  Cross-sectional relations of serum aldosterone and urine sodium excretion to urinary albumin excretion in a community-based sample.

Authors:  C S Fox; M G Larson; S-J Hwang; E P Leip; N Rifai; D Levy; E J Benjamin; J M Murabito; J B Meigs; R S Vasan
Journal:  Kidney Int       Date:  2006-06       Impact factor: 10.612

3.  Estimating 24-Hour Urinary Sodium Excretion From Spot Urine Samples in Chronic Kidney Disease Patients.

Authors:  Jiachang Hu; Yimei Wang; Nana Song; Xiaoyan Zhang; Jie Teng; Jianzhou Zou; Xiaoqiang Ding
Journal:  J Ren Nutr       Date:  2019-04-05       Impact factor: 3.655

Review 4.  Renal function in relation to sodium intake: a quantitative review of the literature.

Authors:  Kyoko Nomura; Kei Asayama; Lotte Jacobs; Lutgarde Thijs; Jan A Staessen
Journal:  Kidney Int       Date:  2017-04-12       Impact factor: 10.612

5.  Urinary Sodium and Potassium Excretion and CKD Progression.

Authors:  Jiang He; Katherine T Mills; Lawrence J Appel; Wei Yang; Jing Chen; Belinda T Lee; Sylvia E Rosas; Anna Porter; Gail Makos; Matthew R Weir; L Lee Hamm; John W Kusek
Journal:  J Am Soc Nephrol       Date:  2015-09-17       Impact factor: 10.121

6.  Sodium intake affects urinary albumin excretion especially in overweight subjects.

Authors:  J C Verhave; H L Hillege; J G M Burgerhof; W M T Janssen; R T Gansevoort; G J Navis; D de Zeeuw; P E de Jong
Journal:  J Intern Med       Date:  2004-10       Impact factor: 8.989

7.  Sodium Excretion and the Risk of Cardiovascular Disease in Patients With Chronic Kidney Disease.

Authors:  Katherine T Mills; Jing Chen; Wei Yang; Lawrence J Appel; John W Kusek; Arnold Alper; Patrice Delafontaine; Martin G Keane; Emile Mohler; Akinlolu Ojo; Mahboob Rahman; Ana C Ricardo; Elsayed Z Soliman; Susan Steigerwalt; Raymond Townsend; Jiang He
Journal:  JAMA       Date:  2016 May 24-31       Impact factor: 56.272

8.  Association of the estimated 24-h urinary sodium excretion with albuminuria in adult koreans: the 2011 Korea National Health and Nutrition Examination Survey.

Authors:  Sang Youb Han; Jae Won Hong; Jung Hyun Noh; Dong-Jun Kim
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

Review 9.  Dietary Salt Restriction in Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials.

Authors:  Carlo Garofalo; Silvio Borrelli; Michele Provenzano; Toni De Stefano; Carlo Vita; Paolo Chiodini; Roberto Minutolo; Luca De Nicola; Giuseppe Conte
Journal:  Nutrients       Date:  2018-06-06       Impact factor: 5.717

10.  Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide.

Authors:  John Powles; Saman Fahimi; Renata Micha; Shahab Khatibzadeh; Peilin Shi; Majid Ezzati; Rebecca E Engell; Stephen S Lim; Goodarz Danaei; Dariush Mozaffarian
Journal:  BMJ Open       Date:  2013-12-23       Impact factor: 2.692

View more
  2 in total

1.  Association between the urinary sodium-to-potassium ratio and renal outcomes in patients with chronic kidney disease: a prospective cohort study.

Authors:  Yuta Matsukuma; Masaru Nakayama; Susumu Tsuda; Akiko Fukui; Ryota Yoshitomi; Kazuhiko Tsuruya; Toshiaki Nakano; Takanari Kitazono
Journal:  Hypertens Res       Date:  2021-09-03       Impact factor: 3.872

2.  Current antihypertensive treatment and treatment-resistant hypertension in Japanese patients with chronic kidney disease.

Authors:  Akihiro Tsuchimoto; Shigeru Tanaka; Hiromasa Kitamura; Hiroto Hiyamuta; Kazuhiko Tsuruya; Takanari Kitazono; Toshiaki Nakano
Journal:  Clin Exp Nephrol       Date:  2022-08-04       Impact factor: 2.617

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.